文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

新冠疫情期间中国2020年和2021年出生儿童24月龄疫苗接种覆盖率:基于国家免疫规划信息系统的研究

Vaccination coverage by age 24 months among children born in 2020 and 2021 in China, during the COVID-19 pandemic: A study based on the national immunization information system.
PubMed 文献 · Vaccine · 2025-09-12

研究从浙江、重庆、山西三省各随机抽取三个县,利用省级免疫规划信息系统评估2020—2021年出生儿童的国家免疫规划疫苗接种率及新冠疫情影响。除百白破疫苗第4剂外,多数疫苗覆盖率超过90.00%目标,但较2015—2019年出生儿童显著下降;及时接种率从百白破疫苗第4剂的78.96%到乙肝疫苗第2剂的97.74%不等。

要点

  • 2020—2021年出生儿童除百白破疫苗第4剂外,国家免疫规划疫苗覆盖率均超过90.00%目标,范围从脊灰疫苗第3剂的90.09%到乙肝疫苗第1剂的99.21%。
  • 与2015—2019年出生儿童相比,2020—2021年出生儿童除卡介苗和乙肝疫苗第1剂外,多数疫苗覆盖率显著下降(所有P值<0.05)。
  • 及时接种率从百白破疫苗第4剂的78.96%到乙肝疫苗第2剂的97.74%,延迟主要原因包括漏种(54.9%)和延迟接种(41.0%)。

核心结论

  • 尽管面临新冠疫情挑战,中国仍维持较高的国家免疫规划疫苗覆盖率,但部分疫苗覆盖率出现下降。
  • 地区差异提示需要有针对性的干预措施以改善免疫服务、确保及时保护并应对社会经济和卫生资源差距。

研究设计与样本

  • 从中国浙江、重庆、山西三省各随机抽取三个县,从省级免疫规划信息系统调取2020—2021年出生儿童的接种记录。
  • 采用描述性流行病学方法和卡方检验比较不同地区和出生队列的疫苗接种覆盖率,并应用Kaplan-Meier法估算特定年龄的接种覆盖率。

主要发现

  • 2020—2021年出生儿童除百白破疫苗第4剂外,国家免疫规划疫苗覆盖率均超过90.00%目标,范围从脊灰疫苗第3剂的90.09%(95%CI,90.07-90.47%)到乙肝疫苗第1剂的99.21%(95%CI,99.15-99.27%)。
  • 与2015—2019年出生儿童相比,2020—2021年出生儿童除卡介苗和乙肝疫苗第1剂外,多数疫苗覆盖率显著下降(所有P值<0.05)。
  • 及时接种率从百白破疫苗第4剂的78.96%(95%CI,78.70-79.25%)到乙肝疫苗第2剂的97.74%(95%CI,97.65-97.84%)。
  • 接种延迟的主要原因为漏种(54.9%)和延迟接种(41.0%)。
  • 疫苗接种覆盖率和及时性均观察到显著地区差异(所有P值<0.05)。

临床怎么用

  • 原文结论指出,地区差异提示需要有针对性的干预措施以改善免疫服务、确保及时保护并应对社会经济和卫生资源差距。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to evaluate the vaccination status of the National Immunization Program (NIP) among children born in 2020-2021 in China and assess the impact of the COVID-19 pandemic on vaccination coverage. METHODS: Three counties were randomly selected from each of the provinces of Zhejiang, Chongqing, and Shanxi in China. Vaccination records were retrieved from provincial immunization information systems. Statistical analyses were conducted using descriptive epidemiological methods and chi-square tests to compare vaccination coverage across different regions and birth cohorts. The Kaplan-Meier method was also applied to estimate vaccination coverage at specific ages. RESULTS: Except DTaP4, NIP vaccination coverage for children born in 2020-2021 remained high, exceeding the 90.00 % target. Coverage ranged from 90.09 % for PV3 (95 % CI, 90.07-90.47 %) to 99.21 % for HepB1 (95 % CI, 99.15-99.27 %). However, compared to children born during 2015-2019, coverage for most vaccines (excluding BCG and HepB1) among those born in 2020-2021 significantly declined (all P-values <0.05). Regarding timeliness, the timely vaccination coverage for NIP vaccines ranged from 78.96 % (95 % CI, 78.70-79.25 %) for DTaP4 to 97.74 % (95 % CI, 97.65-97.84 %) for HepB2. The primary reasons for vaccination delays were missed doses (54.9 %) and delayed administration (41.0 %). Significant regional differences in vaccination coverage and timeliness were also observed (all P-values <0.05). CONCLUSIONS: Despite pandemic challenges, China maintained high NIP coverage, though some declines occurred. Regional differences highlight the need for targeted interventions to improve immunization services, ensure timely protection, and address socioeconomic and health resource disparities.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Huang W, Xu M, Diao Z, et al. Vaccination coverage by age 24 months among children born in 2020 and 2021 in China, during the COVID-19 pandemic: A study based on the national immunization information system. Vaccine. 2025. PMID: 40945181. doi:10.1016/j.vaccine.2025.127717

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。